CY1122138T1 - Νεα ενωση και διαδικασια - Google Patents

Νεα ενωση και διαδικασια

Info

Publication number
CY1122138T1
CY1122138T1 CY20191101046T CY191101046T CY1122138T1 CY 1122138 T1 CY1122138 T1 CY 1122138T1 CY 20191101046 T CY20191101046 T CY 20191101046T CY 191101046 T CY191101046 T CY 191101046T CY 1122138 T1 CY1122138 T1 CY 1122138T1
Authority
CY
Cyprus
Prior art keywords
procedure
compound
formula
new union
relates
Prior art date
Application number
CY20191101046T
Other languages
Greek (el)
English (en)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of CY1122138T1 publication Critical patent/CY1122138T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CY20191101046T 2016-07-28 2019-10-04 Νεα ενωση και διαδικασια CY1122138T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
CY1122138T1 true CY1122138T1 (el) 2020-11-25

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101046T CY1122138T1 (el) 2016-07-28 2019-10-04 Νεα ενωση και διαδικασια

Country Status (19)

Country Link
US (1) US10710998B2 (OSRAM)
EP (1) EP3490988B1 (OSRAM)
JP (1) JP6985367B2 (OSRAM)
KR (1) KR102396059B1 (OSRAM)
CN (1) CN109641891B (OSRAM)
CY (1) CY1122138T1 (OSRAM)
DK (1) DK3490988T3 (OSRAM)
ES (1) ES2751948T3 (OSRAM)
GB (1) GB201613054D0 (OSRAM)
HR (1) HRP20192109T1 (OSRAM)
HU (1) HUE046509T2 (OSRAM)
LT (1) LT3490988T (OSRAM)
PL (1) PL3490988T3 (OSRAM)
PT (1) PT3490988T (OSRAM)
RS (1) RS59566B1 (OSRAM)
SI (1) SI3490988T1 (OSRAM)
SM (1) SMT201900582T1 (OSRAM)
TW (1) TWI739871B (OSRAM)
WO (1) WO2018020249A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3231444T1 (sl) 2014-05-12 2020-04-30 Verona Pharma Plc Novo zdravljenje
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
EP4090654B1 (en) * 2020-01-17 2025-07-09 Lupin Limited Methods, processes and intermediates for preparing chroman compounds
JP2024517583A (ja) 2021-04-29 2024-04-23 ▲蘇▼州盛迪▲亞▼生物医▲薬▼有限公司 イソキノリノン系化合物及びその用途
WO2023109802A1 (zh) * 2021-12-14 2023-06-22 海思科医药集团股份有限公司 三环稠杂环类pde3/4双重抑制及其用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
TW202506117A (zh) 2023-06-26 2025-02-16 英商維羅納製藥Plc公司 顆粒組成物
US20250073240A1 (en) 2023-09-06 2025-03-06 Verona Pharma Plc New treatment
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025168706A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1237429A (en) 1983-05-05 1988-05-31 Frank Kienzle Pyrimidone derivatives
EP1165558B1 (en) 1999-03-31 2003-09-24 Vernalis Limited Derivatives of pyrimido[6,1-a]isoquinolin-4-one
PH12013500261A1 (en) 2010-08-09 2013-03-04 Verona Pharma Plc Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound
PT2968313T (pt) 2013-03-15 2018-02-21 Verona Pharma Plc Combinação de fármacos
SI3231444T1 (sl) 2014-05-12 2020-04-30 Verona Pharma Plc Novo zdravljenje
DK3494962T3 (da) 2014-09-15 2021-06-21 Verona Pharma Plc Flydende inhalationsformulering omfattende RPL554
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
RS59566B1 (sr) 2019-12-31
TWI739871B (zh) 2021-09-21
EP3490988A1 (en) 2019-06-05
TW201806951A (zh) 2018-03-01
KR102396059B1 (ko) 2022-05-10
JP6985367B2 (ja) 2021-12-22
CN109641891B (zh) 2021-05-04
HUE046509T2 (hu) 2020-03-30
SI3490988T1 (sl) 2019-11-29
EP3490988B1 (en) 2019-08-28
ES2751948T3 (es) 2020-04-02
KR20190034231A (ko) 2019-04-01
GB201613054D0 (en) 2016-09-14
US20190330206A1 (en) 2019-10-31
PL3490988T3 (pl) 2020-02-28
SMT201900582T1 (it) 2019-11-13
LT3490988T (lt) 2019-10-10
PT3490988T (pt) 2019-10-28
WO2018020249A1 (en) 2018-02-01
HRP20192109T1 (hr) 2020-02-21
DK3490988T3 (da) 2019-10-28
CN109641891A (zh) 2019-04-16
JP2019527228A (ja) 2019-09-26
US10710998B2 (en) 2020-07-14

Similar Documents

Publication Publication Date Title
CY1122138T1 (el) Νεα ενωση και διαδικασια
CY1121395T1 (el) Τετραϋδροπυριδοπυραζινες-διαμορφωτες toy gpr6
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
CY1124187T1 (el) Ετεροκυκλικα αμιδια ως αναστολεις κινασης
CY1124620T1 (el) Οξυστερολες και μεθοδοι χρησης αυτων
CY1125230T1 (el) Οξυστερολες και μεθοδοι χρησης αυτων
CY1120029T1 (el) Παραγωγα 6-(5-υδροξυ-1η-πυραζολ-1-υλ) νικοτιναμιδιου και χρηση τους ως αναστολεις phd
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
CY1115945T1 (el) Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση
JOP20190066A1 (ar) مركبات حلقية ثنائية النيوكليوتيد
UY37608A (es) Derivados de pirrolo[1,2-b]piridazina
EA201890751A1 (ru) Противогрибковые соединения и способы их получения
CY1119678T1 (el) Πυριμιδινονες ως αναστολεις τελεστη χια
CY1118656T1 (el) Παραγωγο πυριδονης
CY1124450T1 (el) Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων
CY1118883T1 (el) Μεθοδος παρασκευης βορτιοξετινης
CO2017012566A2 (es) Piridinas sustituidas y método de uso
EA201792067A1 (ru) Противогрибковые соединения и способы получения
EA201990455A1 (ru) КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
CY1125082T1 (el) Υποκατεστημενα τριαζολια και μεθοδοι που σχετιζονται με αυτα
MX368882B (es) Proceso para la preparacion de triazinas.
CY1121650T1 (el) Αναστολεις συνθασης αλδοστερονης
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
MX369556B (es) Procesos para la preparacion de derivados acidos de n-acetilgalactosamina (galnac).